Intelligence / Semax

Semax

Prescription Only
Cognitive / Nootropic
Schedule
S4
Prescription Only
Enforcement
Stable
Low Risk
Providers
2
Access: Limited
Key Facts
Schedule 4 - Prescription Only
Synthetic neuropeptide derived from ACTH
Studied for cognitive function and stress resilience
FDA Category 1 reclassification expected (US)
Very limited AU prescription availability

Overview

Semax is a synthetic neuropeptide derived from ACTH, studied for cognitive function and stress resilience. FDA Category 1 reclassification is expected in the US. Very limited prescription availability in Australia, with most supply coming through research suppliers.

Australian Scheduling

Schedule 4 (Prescription Only). Very few Australian providers offer Semax. FDA Category 1 reclassification expected (US). Personal importation is the primary access pathway for most users.

Access Pathway

Very limited prescription availability with 2 identified providers. Most Australian access is through research suppliers or the Personal Importation Scheme.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.